The unified Parkinsons disease rating scale (UPDRS), later upgraded by the expert group of Movement Disorder Society (MDS-UPDRS) in 2008, takes into consideration of motor disability, motor complications, activities of daily living, non-motor symptoms, including changes in mood, behavior, and intellectual functions (Martnez-Martn et al., 2015)
We describe the evaluation and 12-week course of treatment, correlating the capillary beta-hydroxybutyrate/glucose ketone index (BHB/GKI) with time to remission and improvements in metabolic health and QoL
Feb 2001;34(1):65-70
Sudchada P, Saokaew S, Sridetch S, et al
Other possible neurological symptoms are vision changes, confusion, lack of co-ordination, irritability and memory loss
Regular monitoring: Ongoing bloodwork to catch any concerning trends